SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

UCO Bank, Shilpa Medicare and Bajaj Finserv to see some action today

Shilpa Medicare Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 530549 | NSE: SHILPAMED

13 Jul 2022 Evaluate

UCO Bank has received shareholders' approval to raise equity capital by way of issuing up to 100 crore shares. The bank would raise equity capital at appropriate time in the current fiscal to support growth.

Shilpa Medicare’s newly commissioned facility for manufacture and testing of Orodispersible films and Transdermal systems situated at Dabaspet, Bengaluru, Karnataka State, has been issued GMP Certificate by UK Medicines and Healthcare products Regulatory Agency (MHRA). The facility was inspected by MHRA from April 18, 2022 to April 20, 2022.

Bajaj Finserv’s subsidiary company -- Bajaj Allianz Life Insurance has entered into a strategic partnership with City Union Bank to offer its life insurance solutions to the customers of the Tamil Nadu-based bank. Through this partnership, City Union Bank customers will be able to fulfill their long-term financial goals by investing in Bajaj Allianz Life value-packed products ranging from term, savings, retirement, investment solutions.

Syngene International has entered into an agreement for the purpose of acquisition of renewable power by acquiring equity stake up to 26% in Ampyr Renewable Energy Resources Eleven (AREREPL), Special Purpose Vehicle formed by Ampyr India Asset Holdings, for generation and supply of solar power.

Rail Vikas Nigam’s (RVNL) consortium -- RVNL-SP Singla Constructions has been awarded Letter of Acceptance (LoA) by National Highways Authority of India (NHAI) on July 11, 2022 regarding construction of 4 laning of NH-5 from Kaithlighat to Shakral Village (Shimla Bypass Package I: from Km 128.835 to Km 146.300 for Design Length = 17.465 km) in Himachal Pradesh on Hybrid Annuity Mode. The total estimated cost of the project is Rs 1844.77 crore.

Delta Corp has reported results for first quarter ended June 30, 2022. The company has reported net profit at Rs 46.27 crore for the quarter under review as compared to net loss of Rs 11.63 crore for the same quarter in the previous year. Total income of the company reported over 4-fold jump at Rs 155 crore for Q1FY23 as compared Rs 33.95 crore for the corresponding quarter previous year. On the consolidated basis, the company has reported net profit at Rs 57.13 crore for the quarter under review as compared to net loss of Rs 28.93 crore for the same quarter in the previous year. Total income of the company reported 3-fold jump at Rs 256.33 crore for Q1FY23 as compared Rs 82.72 crore for the corresponding quarter previous year.

Indian Overseas Bank has decided to increase the interest rates offered on the medium term deposits by 05 basis points. Now the interest rates offered under term deposits above 1 Year to less than 2 Year will be 5.45% and for 444 days will be 5.50%.

Shilpa Medicare Share Price

411.55 0.30 (0.07%)

17-Apr-2026 16:59 View Price Chart

Peers

Company Name	CMP
Sun Pharma Inds.	1675.20
Dr. Reddys Lab	1235.40
Cipla	1238.30
Zydus Lifesciences	942.55
Lupin	2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

UCO Bank, Shilpa Medicare and Bajaj Finserv to see some action today

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.